CDP-DG(i-16:0/i-19:0) (BioCAD00000110459)

{$topic}

Metabolite Card

Formula: C47H87N3O15P2 (995.5612)
SMILES: [H][C@@](COC(=O)CCCCCCCCCCCCC(C)C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCCCCCCC(C)C

Synonyms [en]

1-isohexadecanoyl-2-isononadecanoyl-sn-glycero-3-cytidine-5'-diphosphate; CDP-DG(35:0); 1-isohexadecanoyl-2-isononadecanoyl-sn-glycero-3-CDP; {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(17-methyloctadecanoyl)oxy]-3-[(14-methylpentadecanoyl)oxy]propoxy]phosphoryl}oxy)phosphinic acid; {[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(17-methyloctadecanoyl)oxy]-3-[(14-methylpentadecanoyl)oxy]propoxy]phosphoryl}oxy)phosphinate; CDP-DG(i-16:0/i-19:0)

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

CDP-DG(i-16:0/i-19:0). 数据之源，洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000110459). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

CDP-DG(i-16:0/i-19:0) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(i-16:0/i-19:0), in particular, consists of one chain of isohexadecanoic acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05% or so of the total phospholipids).

Entity Information

DBLinks

  • CAS Registry Number:
  • PubChem CID: 131822892
  • ChEBI:
  • HMDB: HMDB0116236
  • LipidMaps:
  • KEGG:
  • BioCyc:
  • NCBI MeSH:
  • Wikipedia:
Other DBLinks
  • PubChem: 131822892
  • HMDB: HMDB0116236

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0047382 Cardiolipin Biosynthesis CL(a-13:0/i-18:0/i-16:0/i-19:0)
PathBank:SMP0048026 Cardiolipin Biosynthesis CL(a-13:0/i-20:0/i-16:0/i-19:0)
PathBank:SMP0048346 Cardiolipin Biosynthesis CL(a-13:0/i-21:0/i-16:0/i-19:0)
PathBank:SMP0049315 Cardiolipin Biosynthesis CL(i-12:0/18:2(9Z,11Z)/i-16:0/i-19:0)
PathBank:SMP0050284 Cardiolipin Biosynthesis CL(i-12:0/a-17:0/i-16:0/i-19:0)
PathBank:SMP0052225 Cardiolipin Biosynthesis CL(i-12:0/i-15:0/i-16:0/i-19:0)
PathBank:SMP0052870 Cardiolipin Biosynthesis CL(i-12:0/i-17:0/i-16:0/i-19:0)
PathBank:SMP0053194 Cardiolipin Biosynthesis CL(i-12:0/i-18:0/i-16:0/i-19:0)
PathBank:SMP0054807 Cardiolipin Biosynthesis CL(i-12:0/i-24:0/i-16:0/i-19:0)
PathBank:SMP0055131 Cardiolipin Biosynthesis CL(i-13:0/18:2(9Z,11Z)/i-16:0/i-19:0)
PathBank:SMP0055456 Cardiolipin Biosynthesis CL(i-13:0/a-13:0/i-16:0/i-19:0)
PathBank:SMP0057077 Cardiolipin Biosynthesis CL(i-13:0/i-12:0/i-16:0/i-19:0)
PathBank:SMP0058378 Cardiolipin Biosynthesis CL(i-13:0/i-16:0/i-16:0/i-19:0)
PathBank:SMP0061021 Cardiolipin Biosynthesis CL(i-14:0/a-13:0/i-16:0/i-19:0)
PathBank:SMP0061621 Cardiolipin Biosynthesis CL(i-14:0/a-17:0/i-16:0/i-19:0)
PathBank:SMP0062485 Cardiolipin Biosynthesis CL(i-14:0/i-14:0/i-16:0/i-19:0)
PathBank:SMP0043836 Cardiolipin Biosynthesis CL(a-13:0/a-13:0/i-16:0/i-19:0)
PathBank:SMP0044480 Cardiolipin Biosynthesis CL(a-13:0/a-17:0/i-16:0/i-19:0)
PathBank:SMP0044804 Cardiolipin Biosynthesis CL(a-13:0/a-21:0/i-16:0/i-19:0)
PathBank:SMP0045449 Cardiolipin Biosynthesis CL(a-13:0/i-12:0/i-16:0/i-19:0)
View All Pathways